Sebenzile K Myeni

7PUBLICATIONS
38CO-AUTHORS
Medical infection agents (incl. prions)Genetically modified animalsPredictive and prognostic markersInfectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2025
HCoV-229E Mpro Suppresses RLR-Mediated Innate Immune Signalling Through Cleavage of NEMO and Through Other Mechanisms.

Xavier Martiáñez-Vendrell, Puck B van Kasteren, Sebenzile K Myeni

|Jul 27, 2024
Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine.

Sebenzile K Myeni, Anouk A Leijs, Peter J Bredenbeek

|Feb 24, 2024
The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response.

Mariska van Huizen, Xavier M Vendrell, Heidi L M de Gruyter

|Feb 28, 2023
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.

Sebenzile K Myeni, Peter J Bredenbeek, Robert C M Knaap

|Sep 09, 2022
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance.

Mihaela Zlei, Igor A Sidorov, Simone A Joosten

|Jul 08, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.

Iris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht

Pageof 2

Frequent Collaborators

7 joint publications

Marjolein Kikkert

3 joint publications

Eric J Snijder

2 joint publications

Serge A L Zander

1 joint publications

Nadia Oreshkova